Establishment of highly sensitive analytical method for chondroitin sulfate by flow injection chemiluminescence
Siying Zhang1, Guanglian Zhou2, Xiao Zhang3
1School of Pharmaceutical Sciences, Shandong University, Jinan 250012, China.
Abstract:
A simple and sensitive flow injection chemiluminescence (FI-CL) method has been developed for the determination of chondroitin sulfate (CS). The method is based on the sensitization effect of enzymatic products of CS on the luminol-H2O2 system. Experimental parameters affecting FI-CL method such as concentrations of luminol, H2O2 and NaOH and the standing time of luminol alkaline solution were optimized. Under optimum conditions, the calibration plot between CS concentration and the change of CL intensity was linear in the range of 25 ng/mL∼250 ng/mL. The limit of detection (LOD) was 5 ng/mL and the average relative standard deviation (RSD) of CL intensity was 2.5%. The method was successfully applied to the quantitative analysis of CS concentration in drugs. Compared with the reported methods so far, the established method is simple, sensitive, accurate and rapid.
More Related Videos
05:55Synthesis and Characterization of Placental Chondroitin Sulfate A plCSA-Targeting Lipid-Polymer Nanoparticles
Published on: September 18, 2018
08:25Measuring Nitrite and Nitrate, Metabolites in the Nitric Oxide Pathway, in Biological Materials using the Chemiluminescence Method
Published on: December 25, 2016
Related Concept Videos
Development of Analytical Methods
Sulfate Attack on Concrete
Sulfates from sources like soil, groundwater, or industrial effluents...
Analyte Adsorption and Distribution
Jung's Analytical Theory
Graphical and Analytic Representation of Sinusoids
The first step is measuring the peak-to-peak value, which is twice the amplitude of the sinusoid. This provides information about the maximum voltage swing of the waveform.
Secondly, the period and angular frequency are determined. The period is the time taken for one complete cycle of the waveform, while...
Clinically Relevant Drug Product Specifications: Methods of Establishment
